CSIMarket Company Name, Ticker, Suppliers, else..
 
Terns Pharmaceuticals Inc   (NASDAQ: TERN)
 

Terns Pharmaceuticals Inc's Suppliers Performance

TERN's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
TERN Costs vs Sales of Suppliers Growth

• More on TERN Suppliers






Terns Pharmaceuticals Inc's Comment on Supply Chain


The company depends on third-party suppliers and manufacturers for raw materials and drug components required for clinical trials and potential commercial production. There are a limited number of suppliers for these materials, and the company does not control the acquisition process or timing. The company has no specific agreements for commercial production of raw materials. Replacing manufacturers is difficult due to unique manufacturing technologies and regulatory compliance requirements, which may cause delays in drug development and clinical trials. Disruptions in supply or failure to scale manufacturing capacity could delay clinical trials, regulatory approval, and commercial launch, affecting revenue generation.

Terns Pharmaceuticals Inc's Comment on Supply Chain


The company depends on third-party suppliers and manufacturers for raw materials and drug components required for clinical trials and potential commercial production. There are a limited number of suppliers for these materials, and the company does not control the acquisition process or timing. The company has no specific agreements for commercial production of raw materials. Replacing manufacturers is difficult due to unique manufacturing technologies and regulatory compliance requirements, which may cause delays in drug development and clinical trials. Disruptions in supply or failure to scale manufacturing capacity could delay clinical trials, regulatory approval, and commercial launch, affecting revenue generation.







TERN's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Terns Pharmaceuticals Inc 4,933.17 0.00 -96.21 59
SUBTOTAL 0.00 0.00 0.00 -


Sources: Terns Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Terns Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.